In men with symptomatic advanced prostate cancer, orchiectomy may be prevented by treatment with abarelix

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1417, 2003-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer

By Mongiat-Artus Pierre   Teillac Pierre  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2171-2179

Informa Healthcare

Access to resources Recommend Favorite

Prostate cancer: society prefers orchiectomy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 294, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

PADT may not survive for elderly men with prostate cancer

By  

Inpharma, Vol. 1, Iss. 1646, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

The Treatment of Advanced Prostate Cancer with Ketoconazole: Safety Issues

By Bok R.A.   Small E.J.  

Drug Safety, Vol. 20, Iss. 5, 1999-05 ,pp. : 451-458

Adis International

Access to resources Recommend Favorite

Spotlight on Bicalutamide 150mg in the Treatment of Locally Advanced Prostate Cancer

By Wellington Keri   Keam Susan J.  

Drugs & Aging, Vol. 24, Iss. 2, 2007-01 ,pp. : 169-171

Adis International

Access to resources Recommend Favorite